«OrbiMed»
OrbiMed
Non-Profits
Healthcare-focused investment firm.
Invests into
AbCellera Biologics
Achilles Therapeutics
Adaptimmune
Adicet Bio
Alector
Arrowhead Pharmaceuticals
Artemis
Aspen Neuroscience
Athersys
Atox Bio
Auxilium Pharmaceuticals
Avitide
Azura Ophthalmics
Bellus Health
Betterview
Caris Life Sciences
Carrot Fertility
cCAM Biotherapeutics
Century Therapeutics
CHARM Therapeutics
Cogent Biosciences
Complete Genomics
Computable
CrowdAI
Crown Bioscience
Deepgram
DigitalGenius
Eddingpharm (Cayman)
Enyo Pharma
Erasca
Fore Biotherapeutics
Garuda Therapeutics
Gracell Biotechnologies
Harbour BioMed
Harpoon Therapeutics
I-Mab Biopharma
ImmPACT Bio
ImVitro
Insilico Medicine
Inspire Medical Systems
Intellia Therapeutics
Intercept Pharmaceuticals
InventisBio
Invitae
Iovance Biotherapeutics
KaNDy Therapeutics
Keystone Heart
LifeCell International
MacroGenics
Magenta Therapeutics
MDClone
Mitoconix Bio
MobileODT
Natera
NeRRe Therapeutics
NovellusDx
Nucleix
ObsEva
Odyssey Therapeutics
Olema Oncology
Ornim Medical
Owlet
Pandion Therapeutics
Playnomics
Principia Biopharma
RedHill Biopharma
Runway
SAGE Therapeutics
Sailthru
Sense360
Sierra Oncology
Sikka Software
Silverback Therapeutics
Splisense
Switch
Symbiomix Therapeutics
Treeline Biosciences
TytoCare
VectivBio
Verona Pharma
Wayve
X4 Pharmaceuticals
XtalPi
Technology:
Non-Profits
Industry:
Global Health Challenges
Register and Claim Ownership